Table 5.
Author/year | Patients (number) | Depth of bowel wall involvement (%) | Mesenteric nodal involvement (%) | Prognostic significance of pathological variables | Survival of optimally debulked patients |
---|---|---|---|---|---|
O’Hanlan[27](1995) |
66 |
Serosa 41 |
72.7 |
Trend for patients with mesenteric nodal involvement to fail sooner |
26 months |
Muscolaris 42 | |||||
Submucosa 14 | |||||
Mucosa 3 | |||||
Lax[28](1998) |
31 |
Serosa 45 |
64.5 |
Trend for patients with mesenteric nodal involvement to fail sooner |
21 months |
Muscolaris 36 | |||||
Mucosa 19 | |||||
Scarabelli[29](2000) |
66 |
Muscolaris 100 |
37.9 |
Prognostic significance of depth of bowel wall involvement at multivariate analysis for patients with mesenteric node metastases |
5 years |
42.2 % | |||||
Hertel[30](2001) |
73 |
Serosa 38.5 |
Not reported |
Not reported |
Not reported |
Muscolaris 42.4 | |||||
Mucosa 19.1 | |||||
Park[31](2006) |
46 |
Serosa 71.7 |
15.2 |
Prognostic significance of depth of bowel wall involvement only for disease-free survival |
32 months |
Muscolaris + mucosa 28.3 | |||||
Tebes[32](2006) |
99 |
Serosa 33.3 |
Not reported |
Not reported |
Not reported |
Muscolaris 39.4 | |||||
Submucosa 13.1 | |||||
Mucosa 14.2 | |||||
Salani[33](2007) |
31 |
Serosa 48 |
93.5 |
Not reported |
Not reported |
Muscolaris 29 | |||||
Submucosa 7 | |||||
Mucosa 16 | |||||
Gallota[20](2011) |
71 |
Serosa 45 |
51 |
NO |
38 months overall |
Muscolaris 25.4 | |||||
Submucosa 12.7 |
30 months disease-free |
||||
Mucosa 16.9 | |||||
Baiocchi[34](2011) |
41 |
Serosa 34.1 |
70.7 |
Not reported |
Not reported |
Muscolaris 31.7 | |||||
Submucosa 14.6 | |||||
Mucosa 19.5 | |||||
Gouy[35](2012) |
47 |
Serosa 61.7 |
40.4 |
NO |
4 years 60 % |
Muscolaris 19.1 | |||||
Submucosa 6.3 | |||||
Mucosa 12.7 | |||||
Present series |
52 |
Serosa 25 |
42.3 |
Prognostic significance of depth of bowel wall involvement at multivariate analysis |
35.5 months overall |
Muscolaris 67.3 | |||||
Mucosa 7.7 | 32.5 months disease-free |